Shanzhi Wang

Dr. Shanzhi Wang is an Associate Professor in the Department of Pharmaceutical Sciences at St. John’s University’s College of Pharmacy and Health Sciences. He joined in 2022 after serving as Assistant Professor at the University of Arkansas at Little Rock (2016–2022). His research focuses on drug development using biochemical and computational tools, emphasizing enzyme mechanisms, protein engineering, and AI-driven drug discovery.

Education:

• Ph.D. in Biochemistry, Texas A&M University
• B.S. in Clinical Medicine, Jilin University, China

Research Interests: Dr. Wang’s lab investigates drug development strategies targeting cancer, immunology, and infectious diseases. Key areas include:

• Enzyme nuclease inhibitors for genome stability
• Pyroptosis mechanisms in immunotherapy
• Therapeutic protein engineering (non-antibody)
• AI applications in drug design
• CRISPR-based genome editing methods

His work bridges biochemistry, computational biology, and clinical applications.

Publication Trends: Recent works highlight pyroptosis regulation in cancer and inflammation, CRISPR technologies, and AI-driven drug discovery. Cross-disciplinary collaborations span immunology, oncology, and microbiology.

Grants & Teams: Leverages interdisciplinary teams in bioinformatics and experimental biology. Active in collaborative projects on therapeutic protein design and drug resistance mechanisms.